Michael Wiper
Michael Wiper website image

Michael Wiper

Associate

Email

michael.wiper@aoshearman.com

Phone

+1 857 353 4528

Offices

Boston

V-CARD
Michael's practice involves representing innovator companies in complex patent litigation in the pharmaceutical, biotechnology, and other life sciences industries.
His practice encompasses all stages of civil litigation, including pre-suit diligence, motion practice, discovery, and trial. His experience includes a variety of patent litigation matters, including Hatch-Waxman litigation and other district court patent litigation.

Expertise

Experience

Representative matters

  • Esperion Pharmaceuticals, Inc. as NDA-holder and patent owner in ANDA litigation against nine generic drug companies who are seeking approval for generic versions of Experion’s commercial products NEXLETOL® and NEXLIZET®.
  • Trustees of the University of Pennsylvania patent owner representing in connection with asserting infringement of U.S. Patent No. 7,625,558 (methods of treating cancer tumors) by Genentech's Herceptin, Perjeta, and Phesgo products.
  • Alcon in Hatch Waxman patent litigation in the District of Delaware against generic filer Padagis on Simbrinza®, an eye drop for glaucoma and increased intraocular pressure.

Pro bono

  • Working for New York Civil Liberties Union on disciplinary records review of the Buffalo Police Department.

Qualifications

Admissions

Attorney-at-law, State of Massachusetts, US, 2024

Academic

J.D., Cum Laude, Law, Boston College Law School, 2024

B.A., Political Science, Haverford College, 2020

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.